| Joy L Logan, MD | |
|
4475 S L-19 Frontage Road, Suite 101, Green Valley, AZ 85614 | |
| (520) 585-4590 | |
| (520) 398-7540 |
| Full Name | Joy L Logan |
|---|---|
| Gender | Female |
| Speciality | Nephrology |
| Experience | 48 Years |
| Location | 4475 S L-19 Frontage Road, Green Valley, Arizona |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285732859 | NPI | - | NPPES |
| 241711 | Medicaid | AZ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 10447 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Desert Dialysis Sahuarita (dci) | Sahuarita, AZ | Dialysis facility |
| Desert Dialysis Center (dci) | Tucson, AZ | Dialysis facility |
| Tucson Medical Center | Tucson, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Akdhc Llc | 8123912136 | 124 |
News Archive
Fresenius Kabi Pharmaceuticals Holding, Inc.,, the parent company of APP Pharmaceuticals, Inc., announced today that APP and other Fresenius Kabi companies have entered into license and settlement agreements with sanofi-aventis covering patents that apply to Eloxatin® (oxaliplatin injection and oxaliplatin for injection).
Soon, drug delivery that precisely targets cancerous cells without exposing the healthy surrounding tissue to the medication's toxic effects will no longer be an oncologist's dream but a medical reality, thanks to the work of Professor Sylvain Martel, Director of the Nanorobotics Laboratory at Polytechnique Montr-al.
University of South Florida researchers have identified a genetic biomarker for age-related hearing loss, a major breakthrough in understanding and preventing a condition of aging that affects 30 million Americans and greatly diminishes their quality of life.
Northwest Biotherapeutics announced today that it has received approval from the Medicines and Healthcare Products Regulatory Agency (MHRA) of the United Kingdom, for the Company's 300-patient Phase III clinical trial of DCVax-L immune therapy for Glioblastoma multiforme brain cancer (GBM) to proceed in the U.K.
While The Wall Street Journal and Kaiser Health News report on the current dark side of aging in America, The Associated Press offers insights into how baby boomer interest in countering the effects of getting older could lead to billions of dollars in spending.
› Verified 8 days ago
| Entity Name | Banner -- University Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508809427 PECOS PAC ID: 7719899871 Enrollment ID: O20031105000694 |
News Archive
Fresenius Kabi Pharmaceuticals Holding, Inc.,, the parent company of APP Pharmaceuticals, Inc., announced today that APP and other Fresenius Kabi companies have entered into license and settlement agreements with sanofi-aventis covering patents that apply to Eloxatin® (oxaliplatin injection and oxaliplatin for injection).
Soon, drug delivery that precisely targets cancerous cells without exposing the healthy surrounding tissue to the medication's toxic effects will no longer be an oncologist's dream but a medical reality, thanks to the work of Professor Sylvain Martel, Director of the Nanorobotics Laboratory at Polytechnique Montr-al.
University of South Florida researchers have identified a genetic biomarker for age-related hearing loss, a major breakthrough in understanding and preventing a condition of aging that affects 30 million Americans and greatly diminishes their quality of life.
Northwest Biotherapeutics announced today that it has received approval from the Medicines and Healthcare Products Regulatory Agency (MHRA) of the United Kingdom, for the Company's 300-patient Phase III clinical trial of DCVax-L immune therapy for Glioblastoma multiforme brain cancer (GBM) to proceed in the U.K.
While The Wall Street Journal and Kaiser Health News report on the current dark side of aging in America, The Associated Press offers insights into how baby boomer interest in countering the effects of getting older could lead to billions of dollars in spending.
› Verified 8 days ago
| Entity Name | Akdhc Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316902208 PECOS PAC ID: 8123912136 Enrollment ID: O20040211000250 |
News Archive
Fresenius Kabi Pharmaceuticals Holding, Inc.,, the parent company of APP Pharmaceuticals, Inc., announced today that APP and other Fresenius Kabi companies have entered into license and settlement agreements with sanofi-aventis covering patents that apply to Eloxatin® (oxaliplatin injection and oxaliplatin for injection).
Soon, drug delivery that precisely targets cancerous cells without exposing the healthy surrounding tissue to the medication's toxic effects will no longer be an oncologist's dream but a medical reality, thanks to the work of Professor Sylvain Martel, Director of the Nanorobotics Laboratory at Polytechnique Montr-al.
University of South Florida researchers have identified a genetic biomarker for age-related hearing loss, a major breakthrough in understanding and preventing a condition of aging that affects 30 million Americans and greatly diminishes their quality of life.
Northwest Biotherapeutics announced today that it has received approval from the Medicines and Healthcare Products Regulatory Agency (MHRA) of the United Kingdom, for the Company's 300-patient Phase III clinical trial of DCVax-L immune therapy for Glioblastoma multiforme brain cancer (GBM) to proceed in the U.K.
While The Wall Street Journal and Kaiser Health News report on the current dark side of aging in America, The Associated Press offers insights into how baby boomer interest in countering the effects of getting older could lead to billions of dollars in spending.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joy L Logan, MD 6622 N 91st Ave Ste 220, Glendale, AZ 85305-2569 Ph: (602) 759-6883 | Joy L Logan, MD 4475 S L-19 Frontage Road, Suite 101, Green Valley, AZ 85614 Ph: (520) 585-4590 |
News Archive
Fresenius Kabi Pharmaceuticals Holding, Inc.,, the parent company of APP Pharmaceuticals, Inc., announced today that APP and other Fresenius Kabi companies have entered into license and settlement agreements with sanofi-aventis covering patents that apply to Eloxatin® (oxaliplatin injection and oxaliplatin for injection).
Soon, drug delivery that precisely targets cancerous cells without exposing the healthy surrounding tissue to the medication's toxic effects will no longer be an oncologist's dream but a medical reality, thanks to the work of Professor Sylvain Martel, Director of the Nanorobotics Laboratory at Polytechnique Montr-al.
University of South Florida researchers have identified a genetic biomarker for age-related hearing loss, a major breakthrough in understanding and preventing a condition of aging that affects 30 million Americans and greatly diminishes their quality of life.
Northwest Biotherapeutics announced today that it has received approval from the Medicines and Healthcare Products Regulatory Agency (MHRA) of the United Kingdom, for the Company's 300-patient Phase III clinical trial of DCVax-L immune therapy for Glioblastoma multiforme brain cancer (GBM) to proceed in the U.K.
While The Wall Street Journal and Kaiser Health News report on the current dark side of aging in America, The Associated Press offers insights into how baby boomer interest in countering the effects of getting older could lead to billions of dollars in spending.
› Verified 8 days ago
Howard J Rolins, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 400 W Camino Casa Verde, Green Valley, AZ 85614 Phone: 520-625-1760 Fax: 520-648-1394 | |
Dr. Sivamurthy Kyathari, M.D Nephrology Medicare: Accepting Medicare Assignments Practice Location: 514 E Whitehouse Canyon Rd Ste 110, Green Valley, AZ 85614 Phone: 520-689-7030 Fax: 520-395-9796 | |
Rossa Khalaf, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 121 W Esperanza Blvd # 181, Green Valley, AZ 85614 Phone: 520-689-6992 Fax: 520-230-3310 | |
Dr. Marvin B Padnick, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: 4475 S I 19 Frontage Rd Ste 255, Green Valley, AZ 85614 Phone: 520-393-4863 | |
Dr. Fred P Mendoza, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1055 N. Lacanada Blvd, Suite 121, Green Valley, AZ 85614 Phone: 520-547-7770 Fax: 520-547-7775 | |
Ruben Calvillo, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: 1141 S La Canada Dr, Green Valley, AZ 85614 Phone: 520-694-3030 Fax: 520-694-3055 |